Remission of type 2 diabetes mellitus following bariatric surgery: Review of mechanisms and presentation of the concept of 'reversibility'

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 18, Issue 2, 2011, Pages 119-128

  Perugini, Richard A ^a   Malkani, Samir ^b  

^a Department of Surgery ^*  (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

beta cell function; diabetes remission; gastric banding; gastric bypass; gastrointestinal hormones; incretins; malabsorptive bariatric procedures; sleeve gastrectomy

Indexed keywords

GASTROINTESTINAL HORMONE; GLICENTIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; INCRETIN; OXYNTOMODULIN;

ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CALORIC RESTRICTION; ENERGY BALANCE; GASTRECTOMY; GASTRIC BANDING; GASTROINTESTINAL MOTILITY; GASTROJEJUNOSTOMY; HUMAN; INSULIN SENSITIVITY; MALABSORPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTGASTRECTOMY SYNDROME; REMISSION; STOMACH BYPASS;

DIABETES MELLITUS; GASTRIC BYPASS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; OBESITY; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79952368211     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283446c1f     Document Type: Article

References (57)

1. Ariza MA, Vimalananda VG, Rosenzweig JL The economic consequences of diabetes and cardiovascular disease in the United States. Rev Endocr Metab Disord 2010; 11:1-10.
2. Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res 2004; 12:18-24. (Pubitemid 41137483)
3. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222:339-352.
4. Sasaki S, Katagiri A, Tsuji T, et al. Self-reported rate of eating correlates with body mass index in 18-y-old Japanese women. Int J Obes 2003; 27:1405-1410. (Pubitemid 37386491)
5. Flanagan L Measurement of functional pouch volume after gastric bypass procedure. Obes Surg 1996; 6:38-43.
6. Madan AK, Tichansky DS, Phillips JC. Does pouch size matter? Obes Surg 2007; 17:317-320. (Pubitemid 46659290)
7. Mikami D, Needleman B, Narula V, et al. Natural orifice surgery: initial US experience utilizing the StomaphyX device to reduce gastric pouches after Roux-en-Y gastric bypass. Surg Endosc 2010; 24:223-228.
8. Jordan GLJ, Overton RC, De Bakey ME. The postgastrectomy syndrome: studies on pathogenesis. Ann Surg 1957; 145:471-478.
9. Kellum JM, Kuemmerle JF, O'Dorisio TM, et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211:763-770.
10. Orskov C, Holst JJ, Knuhtsen S, et al. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 1986; 119:1467-1475. (Pubitemid 17170509)
11. Holst JJ. Glucagon-like peptide 1: a newly discovered gastrointestinal hor-mone. Gastroenterology 1994; 107:1848-1855. (Pubitemid 24357644)
12. Miholic J, Orskov C, Holst JJ, et al. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gas-trectomy. Dig Dis Sci 1991; 136:1361-1370.
13. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998; 101:515-520. (Pubitemid 28084232)
14. Korner J, Bessler M, Inabnet W, et al. Exaggerated GLP-1 and blunted GIP secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007; 3:597-601. (Pubitemid 350091417)
15. Moŕnigo R, Moizé V, Musri M, et al. GLP-1, PYY, hunger and satiety following gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006; 91. 1735-1740.
16. Laferrère B, Swerdlow N, Bawa B, et al. Rise of oxyntomodulin in responseto oral glucose after gastric bypass surgery in patients with type 2. Diabetes 2010; 95:4072-4076.
17. Cohen MA, Ellis SM, Le Roux CW, et al. Oxyntomodulin suppresses appetite and reducesfood intake in humans.J Clin Endocrinol Metab 2003; 88:4696-4701. (Pubitemid 37357514)
18. Wynne K, Park AJ, Small CJ, et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes 2005; 54:2390-2395. (Pubitemid 41134267)
19. Strader AD, Vahl TP, Jandacek RJ, et al. Weight loss through ileal transposi-tion is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 2005; 288:E447-E453. (Pubitemid 40110655)
20. Patriti A, Facchiano E, Annetti C, et al. Early improvementof glucosetolerance after ileal transposition in a nonobese type 2. Diab Rat Model Obes Surg 2005; 15:1258-1264. (Pubitemid 41565122)
21. Rocca AS, Brubaker PL Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999; 140:1687-1694. (Pubitemid 29149238)
22. Abbott CR, Monteiro1 M, Small CJ, et al. The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005; 1044:127-131. (Pubitemid 40616060)
23. Perugini RA, Li Y, Rosenthal L, et al. Reduced heart rate variability correlates with insulin resistance but not with measures of obesity in population under-going laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2010; 6:237-241.
24. Nault I, Nadreau E, Paquet C, et al. Impact of bariatricsurgery-induced weight loss on heart rate variability. Metabolism 2007; 56:1425-1430. (Pubitemid 47404607)
25. Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose meta-bolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250:234-241.
26. Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg 2009; 9:1515-1521.
27. Tataranni PA, Mingrone G, Raguso CA, et al. Twenty-four-hour energy and nutrient balance in weight stable postobese patients after biliopancreatic diversion. Nutrition 1996; 12:239-244. (Pubitemid 26286458)
28. Strain GW, Gagner M, Pomp A, et al. Comparison of weight loss and body composition changes with four surgical procedures. Surg Obes Relat Dis 2009; 5:582-587.
29. Lugari R, Dei Cas A, Ugolotti D, et al. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Horm Metab Res 2004; 36:111-115. (Pubitemid 38392252)
30. Valverde I, Puente J, Mart́n-Duce A, et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastro-plasty in obese subjects. Obes Surg 2005; 15:387-397. (Pubitemid 40463608)
31. Wing RR, Blair EH, Bononi P, et al. Caloric restriction per se is a significant factor in improvements inglycemiccontrol and insulinsensitivityduring weight loss in obese NIDDM patients. Diabetes Care 1994; 17:30-36.
32. Markovic TP, Jenkins AB, Campbell LV, et al. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 1998; 21:687-694. (Pubitemid 28487056)
33. Solomon TPJ, Haus JM, Kelly KR, et al. Improved pancreatic [beta]-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 2010; 33:1561-1566.
34. Sjöström L, Narbro K, Sjöström CD, et al., for the Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357:741-752. (Pubitemid 47295641)
35. Laferrère B. Effect of gastric bypass surgery on the incretins. Diabetes Metab 2009; 35:513-517.
36. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on ß-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes 2010; 34:462-471.
37. 2. Surg Obes Related Dis 2007; 3:195-197. (Pubitemid 46444706)
38. 2. Obesity Res. 2009. 19. 307-312.
39. Laferrere B, Teixeira J, McGinty J. Effect of weight loss by gastric bypass surgeryversus hypocaloric dieton glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinonol Metab 2008; 93:2479-2485. (Pubitemid 352008510)
40. Pattou F, Beraud G, Arnalsteen L, et al. Restoration of beta cell function after bariatric surgery in type 2 diabetes patients; a prospective controlled study comparing gastric banding and gastric bypass. Obes Surg 2007; 17:1041-1043.
41. DeMaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS Bariatric Surgery Center of Excellence Program as reported in the bariatric outcomes longitudinal database. Ann Surg 2010; 252:559-567.
42. Tourrel C, Bailbe? D, Meile M, et al. Glucagon-like peptide-1 and exendin-4 stimulate b-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 2001; 50:1562-1570. (Pubitemid 33639596)
43. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009; 32:2133-2135.
44. Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010; 24:1005-1010.
45. Caiazzo R, Arnalsteen L, Pigeyre M, et al. Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose. Br J Surg 2010; 97:884-891.
46. Segato G, Busetto L, De Luca M, et al. Weight loss and changes in use of antidiabetic medication in obese type 2 diabetics after laparoscopic gastric banding. Surg Obes Related Dis 2010; 6:132-137.
47. Scopinaro N, Papadia F, Camerini G, et al. Acomparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain themechanismsof resolution oftype2 diabetes bythetwooperations. Obes Surg 2008; 18:1035-1038.
48. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long-term follow-up. Surg Obes Related Dis 2010; 6:249-253.
49. Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetesafter Roux-en-Ygastric bypass. Surg Obes Related Dis 2010; 6:254-259.
50. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and ß-cell function in human subjects; evidencefor a hyperbolic function. Diabetes 1993; 42:1663-1672. (Pubitemid 23318125)
51. Utzschneider KM, Prigeon RL, Faulenbach MJ, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32:335-341.
52. Lorenzo C, Wagenknecht LE, Rewers MJ, et al. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010; 33:2098-2103.
53. Perugini RA, Quarfordt SH, Baker S, et al. Metabolic characterization of nondiabetic severely obese patients undergoing roux-en-y gastric bypass on insulin-glucose homeostasis. J Gastrointest Surg 2007; 11:1083-1090.
54. Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 2010; 14:15-23.
55. Laferrère B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30:1709-1716. (Pubitemid 47036341)
56. Schauer PR, Burguera MD, Ikramuddin B, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238:467-485. (Pubitemid 38176385)
57. Basu R, Breda E, Oberg AL, et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secre-tion, action, and clearance. Diabetes 2003; 52:1738-1748. (Pubitemid 36792465)